beta-cell death inhibitor (Hadassah University Hospital/Hadasit Medical Research Services and Development)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebeta-cell death inhibitor (Hadassah University Hospital/Hadasit Medical Research Services and Development)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHadassah University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHadasit Medical Research Services & Development LtdHadassah University Hospital
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A